A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising
- 1 January 2010
- journal article
- research article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 100 (1) , 24-32
- https://doi.org/10.2105/ajph.2008.153767
Abstract
American Journal of Public Health (AJPH) from the American Public Health Association (APHA) A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising, an article from American Journal of Public Health, Vol 100 Issue 1Keywords
This publication has 66 references indexed in Scilit:
- Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP ReportAnnals of Family Medicine, 2009
- A Wonderful Life or Diarrhea and Dry Mouth? Policy Issues of Direct-to-Consumer Drug Advertising on TelevisionHealth Communication, 2007
- Direct-To-Consumer Advertisements For HIV Antiretroviral Medications: A Progress ReportHealth Affairs, 2007
- A Decade of Direct-to-Consumer Advertising of Prescription DrugsNew England Journal of Medicine, 2007
- Drug Risks and Free Speech — Can Congress Ban Consumer Drug Ads?New England Journal of Medicine, 2007
- Time Allocation in Primary Care Office VisitsHealth Services Research, 2007
- Pharmaceutical Websites and the Communication of Risk InformationJournal of Health Communication, 2007
- Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer AdvertisingAnnals of Family Medicine, 2007
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer ProtectionThe Milbank Quarterly, 2006
- Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisementsPatient Education and Counseling, 2004